The FDA’s approval of Seqirus’ FLUCELVAX QUADRIVALENT brings to market the first flu vaccine of its kind, appropriately made by one of North Carolina’s world-class biomanufacturers.
Global blood therapeutics company Grifols, the largest Spanish company with U.S. facilities, will add two more production facilities to its 233-acre bioprocessing site in Johnston County.
North Carolina's life science leaders are gathering in Raleigh for the annual CED Life Science Conference. Find out what's helping North Carolina break through.
The Durham drug company tells WHO of promising results in global search for a drug to halt the fast-spreading virus linked to birth defects.
SUBSCRIBE to our newsletters
BOOK A MEETING at the
Hamner Conference Center
tel: 919.541.9366 fax: 919.990.9544 firstname.lastname@example.org
15 TW Alexander Drive Post Office Box 13547 Research Triangle Park, NC 27709-3547